Back to search

Netherlands· NL-f5285bc91f08

Ervebo, oplossing voor injectie

A ebola-impfstoffe product containing levend verzwakt recombinant vesiculair stomatitisvirus (rvsv, 11481 nt indiana stam) bevattend zaire-ebola virus (zebov, kikwit 1995 stam) envelop glycoproteine (gp), geproduceerd in vero cellen, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC J07BX02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedErvebo, oplossing voor injectieATCJ07BX02REGISTER NO.NL-f5285bc91f08PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Ebola-impfstoffe is registered in 9 of 19 countries.

Countries holding a registration under ATC J07BX02 (ebola-impfstoffe), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Ebola-impfstoffe · ATC J07BX02

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LEVEND VERZWAKT RECOMBINANT VESICULAIR STOMATITISVIRUS (rVSV, 11481 nt INDIANA STAM) BEVATTEND ZAIRE-EBOLA VIRUS (ZEBOV, KIKWIT 1995 STAM) ENVELOP GLYCOPROTEINE (GP), GEPRODUCEERD IN VERO CELLEN
Manufacturer
Merck Sharp & Dohme B.V.
Country
Netherlands (NL)
ATC code
J07BX02
ATC class
Ebola-Impfstoffe
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/19/1392

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/26083ed3-eeef-47e3-991d-eae068ba7e3a
GET /v1/drugs/26083ed3-eeef-47e3-991d-eae068ba7e3a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ervebo-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Ebola Vaccines",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp124647",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "RECOMBINANT HUMAAN SERUM ALBUMINE, AFGELEID VAN RIJST",
    "TROMETAMOL",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "LEVEND VERZWAKT RECOMBINANT VESICULAIR STOMATITISVIRUS (rVSV, 11481 nt INDIANA STAM) BEVATTEND ZAIRE-EBOLA VIRUS (ZEBOV, KIKWIT 1995 STAM) ENVELOP GLYCOPROTEINE (GP), GEPRODUCEERD IN VERO CELLEN"
  ],
  "leaflet_url": null,
  "authorised_at": "2019/11/11",
  "procedure_number": "EMEA/H/C/004554",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/19/1392",
  "additional_monitoring": "N"
}

See everything about ebola-impfstoffe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.